Regulation of the NF-κB/NLRP3 signalling pathway by Shenghui Yizhi decoction reduces neuroinflammation in mice with Alzheimer’s disease

Oct 11, 2024Annals of medicine

Shenghui Yizhi decoction may reduce brain inflammation in Alzheimer's mice by controlling the NF-κB/NLRP3 pathway

AI simplified

Abstract

SAMP8 mice showed significant cognitive decline and increased inflammation markers associated with Alzheimer's disease.

  • SAMP8 mice exhibited reduced spatial localization, navigation, and exploration abilities compared to a control group.
  • Elevated levels of amyloid β1-42 were found in the hippocampus of SAMP8 mice.
  • Inflammation-related factors, including IL-1β, IL-6, TNF-α, and NLRP3, were significantly increased in these mice.
  • Treatment with SHYZD and donepezil hydrochloride significantly improved learning abilities in the mice.
  • Both amyloid β1-42 levels and inflammatory factors were notably reduced following treatment.

AI simplified

Key numbers

9.1×
Increase in Learning Ability
Dosage of SHYZD based on body surface area conversion.
< 0.01
Reduction in Aβ1-42 Expression
Comparison of Aβ1-42 levels in the SHYZD group vs. model group.
< 0.01
Decrease in Inflammatory Factors
Comparison of inflammatory marker levels in the SHYZD group vs. model group.

Full Text

What this is

  • This research investigates the effects of Shenghui Yizhi decoction (SHYZD) on cognitive function and neuroinflammation in a mouse model of Alzheimer's disease (AD).
  • The study examines how SHYZD regulates the NF-κB/NLRP3 signaling pathway, which is implicated in neuroinflammation and cognitive decline associated with AD.
  • Findings indicate that SHYZD improves learning and memory while reducing inflammatory markers and amyloid β1-42 levels in the hippocampus.

Essence

  • SHYZD enhances cognitive abilities and reduces neuroinflammation in AD mice by modulating the NF-κB/NLRP3 signaling pathway, indicating its potential as a therapeutic agent.

Key takeaways

  • SAMP8 mice displayed impaired learning and memory compared to control mice, with increased Aβ1-42 and inflammatory markers in the hippocampus.
  • Treatment with SHYZD and donepezil hydrochloride significantly improved learning abilities and reduced levels of Aβ1-42, IL-1β, IL-6, and TNF-α in the treated groups.
  • The expression of NLRP3, Caspase-1, and IL-1β was significantly reduced in the SHYZD group, suggesting that SHYZD inhibits neuroinflammation through the NF-κB/NLRP3 pathway.

Caveats

  • The study is limited to a mouse model, which may not fully replicate human AD pathology and treatment responses.
  • Further research is needed to elucidate the specific biological activities and metabolic pathways of SHYZD components in humans.

Definitions

  • NLRP3 inflammasome: A protein complex that activates inflammatory responses and is implicated in neuroinflammation associated with Alzheimer's disease.

AI simplified

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free